Trademark: 98632101
Word
TUMOROL
Status
Pending
Status Code
630
Status Date
Wednesday, July 3, 2024
Serial Number
98632101
Mark Type
4
Filing Date
Wednesday, July 3, 2024

Trademark Owner History

Classifications
5 Tumorol is nutraceutical vitamin used in cancer treatment due to its reported antiproliferative, antimetastatic, and antiangiogenic properties. These activities suggest that Tumorol may inhibit the growth of cancer cells (antiproliferative), prevent the spread of cancer to other parts of the body (antimetastatic), and reduce the formation of new blood vessels that tumors need to grow (antiangiogenic).

Trademark Events
Jul 3, 2024
New Application Entered
Jul 3, 2024
New Application Office Supplied Data Entered

Trademark Alertz updated from USPTO on 2030-01-24